Ligand Pharmaceuticals Down 9.2% Since SmarTrend's Sell Recommendation
Do you know when to trade LGND ?
LGND | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called a Downtrend for Ligand Pharmaceuticals (NASDAQ:LGND) on August 31, 2009 at $2.40.
Since then, Ligand Pharmaceuticals has returned 9.2% as of today's recent price of $2.18. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
For full details on Ligand Pharmaceuticals B (LGND) LGND. Ligand Pharmaceuticals B (LGND) has Short Term PowerRatings at TradingMarkets. Details on Ligand Pharmaceuticals B (LGND) Short Term PowerRatings is available at This Link.
- BiomedReports: News and FDA Updates for Ligand (NASDAQ:LGND), GlaxoSmithKline (NYSE:GSK), MiddleBrook (Nasdaq:MBRK) - 03/15/10
- Ligand Announces Approval for Revolade(R) in Europe - 03/12/10
- SmarTrend's Trend Spotter Sees Continued Downward Momentum on Shares of Ligand Pharmaceuticals (LGND) - 03/11/10
- Ligand Pharmaceuticals: The Trend Continues Lower (LGND) - 03/03/10
- Ligand to Address Cowen & Company 30th Annual Healthcare Conference - 03/03/10
- More News >>


